David A. Siegel Silk Road Medical Inc Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Silk Road Medical Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 756,000 shares of SILK stock, worth $20.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

756,000

Previous 657,400 15.0%

Holding current value

$20.4 Million

Previous $8.07 Million 71.7%

% of portfolio

0.03%

Previous 0.02%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$11.38 - $19.03 $1.12 Million - $1.88 Million	98,600 Added 15.0%	756,000 $13.8 Million
Q4 2023 Feb 14, 2024	BUY	$6.29 - $15.72 $1.46 Million - $3.66 Million	232,900 Added 54.86%	657,400 $8.07 Million
Q3 2023 Nov 14, 2023	BUY	$14.99 - $32.65 $2.14 Million - $4.66 Million	142,800 Added 50.69%	424,500 $6.36 Million
Q2 2023 Aug 14, 2023	BUY	$29.76 - $46.14 $4.17 Million - $6.46 Million	140,100 Added 98.94%	281,700 $9.15 Million
Q1 2023 May 15, 2023	BUY	$38.09 - $57.79 $4.94 Million - $7.5 Million	129,700 Added 1089.92%	141,600 $5.54 Million

Q4 2022 Feb 14, 2023	BUY	$40.54 - $56.2 $482,426 - $668,780	11,900 New	11,900 $628,000
Q3 2021 Nov 15, 2021	SELL	$44.0 - $65.8 $2.32 Million - $3.47 Million	-52,700 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$44.66 - $63.06 $120,581 - $170,262	-2,700 Reduced 4.87%	52,700 $2.52 Million
Q1 2021 May 17, 2021	BUY	$46.31 - $62.7 $2.24 Million - $3.03 Million	48,300 Added 680.28%	55,400 $2.81 Million
Q4 2020 Feb 16, 2021	BUY	$55.51 - $69.94 $394,121 - $496,574	7,100 New	7,100 $447,000

Others Institutions Holding SILK

# of Institutions

157

Shares Held

41.8M

Call Options Held

428K

Put Options Held

199K

View Full List

About Silk Road Medical Inc

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.02B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

More about SILK

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account